Vivimed Labs is currently trading at Rs. 87.00, up by 1.55 points or 1.81% from its previous closing of Rs. 85.45 on the BSE.
The scrip opened at Rs. 85.15 and has touched a high and low of Rs. 88.45 and Rs. 85.15 respectively. So far 75601 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 153.30 on 21-Sep-2017 and a 52 week low of Rs. 75.00 on 06-Feb-2018.
Last one week high and low of the scrip stood at Rs. 89.45 and Rs. 75.00 respectively. The current market cap of the company is Rs. 718.78 crore.
The promoters holding in the company stood at 35.81%, while Institutions and Non-Institutions held 10.14% and 54.05% respectively.
Vivimed Labs’ Unit 1 FDF manufacturing facility located in Hyderabad, post certification by Ukraine FDA, has successfully registered 8 products in anti viral, pain management and cough suppressants segment.
The company has now inked a distribution agreement with ‘Alter Ego LLC’, Kieve, Ukraine which has more than a decade of presence in Ukraine, Russia and CIS regions. The company is expecting revenues upwards of $10 million for FY19 from CIS region.
Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: